Exogenous antigen-driven Th cell–CLL cell interaction has been shown to drive CLL B-cell activation and differentiation into IgM-secreting PCs that did not downregulate HLA and costimulatory molecules or express the PC marker CD138. This evidence concerns the gene CD276 and B-cell chronic lymphocytic leukemia.